1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-tumor Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Cytotoxic Drugs 1.2.3 Non-cytotoxic Drugs 1.3 Market by Application 1.3.1 Global Anti-tumor Drug Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Alkylating Agents 1.3.3 Anti-Metabolism Drugs 1.3.4 Platinum Antineoplastic Agents 1.3.5 Anthracycline Antitumor Drugs 1.3.6 Microtubule Stabilizer 1.3.7 Endocrine Therapy Drugs 1.3.8 Immunotherapy Drugs 1.3.9 Gene Therapy Drugs 1.3.10 Targeted Antineoplastic Drugs 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-tumor Drug Market Perspective (2017-2028) 2.2 Anti-tumor Drug Growth Trends by Region 2.2.1 Anti-tumor Drug Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Anti-tumor Drug Historic Market Size by Region (2017-2022) 2.2.3 Anti-tumor Drug Forecasted Market Size by Region (2023-2028) 2.3 Anti-tumor Drug Market Dynamics 2.3.1 Anti-tumor Drug Industry Trends 2.3.2 Anti-tumor Drug Market Drivers 2.3.3 Anti-tumor Drug Market Challenges 2.3.4 Anti-tumor Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-tumor Drug Players by Revenue 3.1.1 Global Top Anti-tumor Drug Players by Revenue (2017-2022) 3.1.2 Global Anti-tumor Drug Revenue Market Share by Players (2017-2022) 3.2 Global Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Anti-tumor Drug Revenue 3.4 Global Anti-tumor Drug Market Concentration Ratio 3.4.1 Global Anti-tumor Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-tumor Drug Revenue in 2021 3.5 Anti-tumor Drug Key Players Head office and Area Served 3.6 Key Players Anti-tumor Drug Product Solution and Service 3.7 Date of Enter into Anti-tumor Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-tumor Drug Breakdown Data by Type 4.1 Global Anti-tumor Drug Historic Market Size by Type (2017-2022) 4.2 Global Anti-tumor Drug Forecasted Market Size by Type (2023-2028) 5 Anti-tumor Drug Breakdown Data by Application 5.1 Global Anti-tumor Drug Historic Market Size by Application (2017-2022) 5.2 Global Anti-tumor Drug Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Anti-tumor Drug Market Size (2017-2028) 6.2 North America Anti-tumor Drug Market Size by Country (2017-2022) 6.3 North America Anti-tumor Drug Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Anti-tumor Drug Market Size (2017-2028) 7.2 Europe Anti-tumor Drug Market Size by Country (2017-2022) 7.3 Europe Anti-tumor Drug Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Anti-tumor Drug Market Size (2017-2028) 8.2 Asia-Pacific Anti-tumor Drug Market Size by Country (2017-2022) 8.3 Asia-Pacific Anti-tumor Drug Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Anti-tumor Drug Market Size (2017-2028) 9.2 Latin America Anti-tumor Drug Market Size by Country (2017-2022) 9.3 Latin America Anti-tumor Drug Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-tumor Drug Market Size (2017-2028) 10.2 Middle East & Africa Anti-tumor Drug Market Size by Country (2017-2022) 10.3 Middle East & Africa Anti-tumor Drug Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Detail 11.1.2 Roche Business Overview 11.1.3 Roche Anti-tumor Drug Introduction 11.1.4 Roche Revenue in Anti-tumor Drug Business (2017-2022) 11.1.5 Roche Recent Development 11.2 Novartis 11.2.1 Novartis Company Detail 11.2.2 Novartis Business Overview 11.2.3 Novartis Anti-tumor Drug Introduction 11.2.4 Novartis Revenue in Anti-tumor Drug Business (2017-2022) 11.2.5 Novartis Recent Development 11.3 Celgene 11.3.1 Celgene Company Detail 11.3.2 Celgene Business Overview 11.3.3 Celgene Anti-tumor Drug Introduction 11.3.4 Celgene Revenue in Anti-tumor Drug Business (2017-2022) 11.3.5 Celgene Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Detail 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Anti-tumor Drug Introduction 11.4.4 Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2017-2022) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Amgen 11.5.1 Amgen Company Detail 11.5.2 Amgen Business Overview 11.5.3 Amgen Anti-tumor Drug Introduction 11.5.4 Amgen Revenue in Anti-tumor Drug Business (2017-2022) 11.5.5 Amgen Recent Development 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Detail 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Anti-tumor Drug Introduction 11.6.4 Johnson & Johnson Revenue in Anti-tumor Drug Business (2017-2022) 11.6.5 Johnson & Johnson Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Detail 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Anti-tumor Drug Introduction 11.7.4 Pfizer Revenue in Anti-tumor Drug Business (2017-2022) 11.7.5 Pfizer Recent Development 11.8 Takeda 11.8.1 Takeda Company Detail 11.8.2 Takeda Business Overview 11.8.3 Takeda Anti-tumor Drug Introduction 11.8.4 Takeda Revenue in Anti-tumor Drug Business (2017-2022) 11.8.5 Takeda Recent Development 11.9 Eli Lilly 11.9.1 Eli Lilly Company Detail 11.9.2 Eli Lilly Business Overview 11.9.3 Eli Lilly Anti-tumor Drug Introduction 11.9.4 Eli Lilly Revenue in Anti-tumor Drug Business (2017-2022) 11.9.5 Eli Lilly Recent Development 11.10 AstraZeneca 11.10.1 AstraZeneca Company Detail 11.10.2 AstraZeneca Business Overview 11.10.3 AstraZeneca Anti-tumor Drug Introduction 11.10.4 AstraZeneca Revenue in Anti-tumor Drug Business (2017-2022) 11.10.5 AstraZeneca Recent Development 11.11 Astellas 11.11.1 Astellas Company Detail 11.11.2 Astellas Business Overview 11.11.3 Astellas Anti-tumor Drug Introduction 11.11.4 Astellas Revenue in Anti-tumor Drug Business (2017-2022) 11.11.5 Astellas Recent Development 11.12 Merck & Co 11.12.1 Merck & Co Company Detail 11.12.2 Merck & Co Business Overview 11.12.3 Merck & Co Anti-tumor Drug Introduction 11.12.4 Merck & Co Revenue in Anti-tumor Drug Business (2017-2022) 11.12.5 Merck & Co Recent Development 11.13 Sanofi 11.13.1 Sanofi Company Detail 11.13.2 Sanofi Business Overview 11.13.3 Sanofi Anti-tumor Drug Introduction 11.13.4 Sanofi Revenue in Anti-tumor Drug Business (2017-2022) 11.13.5 Sanofi Recent Development 11.14 Bayer 11.14.1 Bayer Company Detail 11.14.2 Bayer Business Overview 11.14.3 Bayer Anti-tumor Drug Introduction 11.14.4 Bayer Revenue in Anti-tumor Drug Business (2017-2022) 11.14.5 Bayer Recent Development 11.15 Biogen Idec 11.15.1 Biogen Idec Company Detail 11.15.2 Biogen Idec Business Overview 11.15.3 Biogen Idec Anti-tumor Drug Introduction 11.15.4 Biogen Idec Revenue in Anti-tumor Drug Business (2017-2022) 11.15.5 Biogen Idec Recent Development 11.16 Eisai 11.16.1 Eisai Company Detail 11.16.2 Eisai Business Overview 11.16.3 Eisai Anti-tumor Drug Introduction 11.16.4 Eisai Revenue in Anti-tumor Drug Business (2017-2022) 11.16.5 Eisai Recent Development 11.17 Teva 11.17.1 Teva Company Detail 11.17.2 Teva Business Overview 11.17.3 Teva Anti-tumor Drug Introduction 11.17.4 Teva Revenue in Anti-tumor Drug Business (2017-2022) 11.17.5 Teva Recent Development 11.18 Otsuka 11.18.1 Otsuka Company Detail 11.18.2 Otsuka Business Overview 11.18.3 Otsuka Anti-tumor Drug Introduction 11.18.4 Otsuka Revenue in Anti-tumor Drug Business (2017-2022) 11.18.5 Otsuka Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anti-tumor Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Cytotoxic Drugs Table 3. Key Players of Non-cytotoxic Drugs Table 4. Global Anti-tumor Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Anti-tumor Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Anti-tumor Drug Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Anti-tumor Drug Market Share by Region (2017-2022) Table 8. Global Anti-tumor Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Anti-tumor Drug Market Share by Region (2023-2028) Table 10. Anti-tumor Drug Market Trends Table 11. Anti-tumor Drug Market Drivers Table 12. Anti-tumor Drug Market Challenges Table 13. Anti-tumor Drug Market Restraints Table 14. Global Anti-tumor Drug Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Anti-tumor Drug Market Share by Players (2017-2022) Table 16. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2021) Table 17. Ranking of Global Top Anti-tumor Drug Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Anti-tumor Drug Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Anti-tumor Drug Product Solution and Service Table 21. Date of Enter into Anti-tumor Drug Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Anti-tumor Drug Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Anti-tumor Drug Revenue Market Share by Type (2017-2022) Table 25. Global Anti-tumor Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Anti-tumor Drug Revenue Market Share by Type (2023-2028) Table 27. Global Anti-tumor Drug Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Anti-tumor Drug Revenue Market Share by Application (2017-2022) Table 29. Global Anti-tumor Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Anti-tumor Drug Revenue Market Share by Application (2023-2028) Table 31. North America Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Anti-tumor Drug Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Anti-tumor Drug Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Anti-tumor Drug Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Anti-tumor Drug Market Size by Country (2023-2028) & (US$ Million) Table 41. Roche Company Detail Table 42. Roche Business Overview Table 43. Roche Anti-tumor Drug Product Table 44. Roche Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 45. Roche Recent Development Table 46. Novartis Company Detail Table 47. Novartis Business Overview Table 48. Novartis Anti-tumor Drug Product Table 49. Novartis Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 50. Novartis Recent Development Table 51. Celgene Company Detail Table 52. Celgene Business Overview Table 53. Celgene Anti-tumor Drug Product Table 54. Celgene Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 55. Celgene Recent Development Table 56. Bristol-Myers Squibb Company Detail Table 57. Bristol-Myers Squibb Business Overview Table 58. Bristol-Myers Squibb Anti-tumor Drug Product Table 59. Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 60. Bristol-Myers Squibb Recent Development Table 61. Amgen Company Detail Table 62. Amgen Business Overview Table 63. Amgen Anti-tumor Drug Product Table 64. Amgen Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 65. Amgen Recent Development Table 66. Johnson & Johnson Company Detail Table 67. Johnson & Johnson Business Overview Table 68. Johnson & Johnson Anti-tumor Drug Product Table 69. Johnson & Johnson Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 70. Johnson & Johnson Recent Development Table 71. Pfizer Company Detail Table 72. Pfizer Business Overview Table 73. Pfizer Anti-tumor Drug Product Table 74. Pfizer Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 75. Pfizer Recent Development Table 76. Takeda Company Detail Table 77. Takeda Business Overview Table 78. Takeda Anti-tumor Drug Product Table 79. Takeda Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 80. Takeda Recent Development Table 81. Eli Lilly Company Detail Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Anti-tumor Drug Product Table 84. Eli Lilly Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 85. Eli Lilly Recent Development Table 86. AstraZeneca Company Detail Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Anti-tumor Drug Product Table 89. AstraZeneca Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 90. AstraZeneca Recent Development Table 91. Astellas Company Detail Table 92. Astellas Business Overview Table 93. Astellas Anti-tumor DrugProduct Table 94. Astellas Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 95. Astellas Recent Development Table 96. Merck & Co Company Detail Table 97. Merck & Co Business Overview Table 98. Merck & Co Anti-tumor DrugProduct Table 99. Merck & Co Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 100. Merck & Co Recent Development Table 101. Sanofi Company Detail Table 102. Sanofi Business Overview Table 103. Sanofi Anti-tumor DrugProduct Table 104. Sanofi Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 105. Sanofi Recent Development Table 106. Bayer Company Detail Table 107. Bayer Business Overview Table 108. Bayer Anti-tumor DrugProduct Table 109. Bayer Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 110. Bayer Recent Development Table 111. Biogen Idec Company Detail Table 112. Biogen Idec Business Overview Table 113. Biogen Idec Anti-tumor DrugProduct Table 114. Biogen Idec Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 115. Biogen Idec Recent Development Table 116. Eisai Company Detail Table 117. Eisai Business Overview Table 118. Eisai Anti-tumor DrugProduct Table 119. Eisai Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 120. Eisai Recent Development Table 121. Teva Company Detail Table 122. Teva Business Overview Table 123. Teva Anti-tumor DrugProduct Table 124. Teva Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 125. Teva Recent Development Table 126. Otsuka Company Detail Table 127. Otsuka Business Overview Table 128. Otsuka Anti-tumor DrugProduct Table 129. Otsuka Revenue in Anti-tumor Drug Business (2017-2022) & (US$ Million) Table 130. Otsuka Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-tumor Drug Market Share by Type: 2021 VS 2028 Figure 2. Cytotoxic Drugs Features Figure 3. Non-cytotoxic Drugs Features Figure 4. Global Anti-tumor Drug Market Share by Application in 2021 & 2028 Figure 5. Alkylating Agents Case Studies Figure 6. Anti-Metabolism Drugs Case Studies Figure 7. Platinum Antineoplastic Agents Case Studies Figure 8. Anthracycline Antitumor Drugs Case Studies Figure 9. Microtubule Stabilizer Case Studies Figure 10. Endocrine Therapy Drugs Case Studies Figure 11. Immunotherapy Drugs Case Studies Figure 12. Gene Therapy Drugs Case Studies Figure 13. Targeted Antineoplastic Drugs Case Studies Figure 14. Anti-tumor Drug Report Years Considered Figure 15. Global Anti-tumor Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 16. Global Anti-tumor Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Anti-tumor Drug Market Share by Region: 2021 VS 2028 Figure 18. Global Anti-tumor Drug Market Share by Players in 2021 Figure 19. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2021) Figure 20. The Top 10 and 5 Players Market Share by Anti-tumor Drug Revenue in 2021 Figure 21. North America Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. North America Anti-tumor Drug Market Share by Country (2017-2028) Figure 23. United States Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Europe Anti-tumor Drug Market Share by Country (2017-2028) Figure 27. Germany Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Anti-tumor Drug Market Share by Region (2017-2028) Figure 35. China Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Japan Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. South Korea Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Southeast Asia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. India Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Australia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Latin America Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Latin America Anti-tumor Drug Market Share by Country (2017-2028) Figure 43. Mexico Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Brazil Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Middle East & Africa Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Anti-tumor Drug Market Share by Country (2017-2028) Figure 47. Turkey Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Saudi Arabia Anti-tumor Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Roche Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 50. Novartis Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 51. Celgene Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 53. Amgen Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 54. Johnson & Johnson Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 55. Pfizer Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 56. Takeda Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 57. Eli Lilly Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 58. AstraZeneca Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 59. Astellas Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 60. Merck & Co Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 61. Sanofi Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 62. Bayer Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 63. Biogen Idec Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 64. Eisai Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 65. Teva Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 66. Otsuka Revenue Growth Rate in Anti-tumor Drug Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Roche Novartis Celgene Bristol-Myers Squibb Amgen Johnson & Johnson Pfizer Takeda Eli Lilly AstraZeneca Astellas Merck & Co Sanofi Bayer Biogen Idec Eisai Teva Otsuka